Paroxysmal nocturnal hemoglobinuria.
Omine, Mitsuhiro; Kinoshita, Taroh; Nakakuma, Hideki; Maciejewski, Jaroslaw P; Parker, Charles J; Socié, Gérard.
Int J Hematol
; 82(5): 417-21, 2005 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16533745
Conditional TRF1 knockout in the hematopoietic compartment leads to bone marrow failure and recapitulates clinical features of dyskeratosis congenita.
Increased glycosylphosphatidylinositol-anchored protein-deficient granulocytes define a benign subset of bone marrow failures in patients with trisomy 8.
Clonal Replacement Underlies Spontaneous Remission in Paroxysmal Nocturnal Haemoglobinuria.
Pathogenesis of paroxysmal nocturnal hemoglobinuria.
Establishment of a flow cytometry assay for detecting paroxysmal nocturnal hemoglobinuria-type cells specific to patients with bone marrow failure.
[Anemia: From Basic Knowledge to Up-to-Date Treatment. Topics: V. Paroxysmal nocturnal hemoglobinuria: The pathophysiology and the current treatment].
Oxidative stress, bone marrow failure, and genome instability in hematopoietic stem cells.
Cell-type-specific transcriptional regulation of PIGM underpins the divergent hematologic phenotype in inherited GPl deficiency.
Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab.
Paroxysmal nocturnal hemoglobinuria clones are not infrequent in patients with inherited bone marrow failure syndromes.